1034 studies found for:    Open Studies | "Diabetes Mellitus, Type 2"
Show Display Options
Rank Status Study
1 Recruiting Arterial Stiffness and Complication Risk in Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Diabetes Complications;   Diabetic Angiopathies;   Diabetic Nephropathies
Intervention:
2 Not yet recruiting Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes (CONSENT)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Metformin XR;   Drug: Metformin IR
3 Recruiting Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Vildagliptin
4 Recruiting Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
Conditions: Acute Coronary Syndrome;   Diabetes Mellitus, Type 2;   Hypertriglyceridemia
Interventions: Drug: Fenofibrate;   Drug: Simvastatin
5 Recruiting Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg;   Drug: Placebo
6 Recruiting A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin 100 mg;   Drug: Canagliflozin 50 mg;   Drug: Canagliflozin 300 mg;   Drug: Placebo
7 Recruiting The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
Conditions: Diabetes Mellitus, Type 2;   Diabetes
Interventions: Drug: Metformin;   Drug: Detemir;   Drug: Liraglutide;   Drug: Insulin Aspart
8 Recruiting A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg;   Drug: Placebo
9 Not yet recruiting Stress Management Among Latinos With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: stress management
10 Recruiting Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
Conditions: Obesity;   Overweight;   Diabetes Mellitus, Type 2
Intervention:
11 Unknown  The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Lipoic acid
12 Not yet recruiting Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Albiglutide;   Drug: Matching albiglutide placebo
13 Recruiting Intervention Study - Effectiveness of Smartphone Delivered Interval Walking Training to Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Other: Interval walking training;   Other: control
14 Not yet recruiting Safety and Efficacy of Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Albiglutide;   Drug: Insulin Glargine and Insulin Lispro
15 Recruiting A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2;   Albuminuria
Interventions: Drug: Placebo;   Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg
16 Unknown  Immunosuppression Impact on the Metabolic Control of First Kidney Transplant Recipients With Pre-Existing Type 2 Diabetes (DM)
Conditions: Kidney Transplant;   Diabetes Mellitus, Type 2;   Diabetic Nephropathy
Interventions: Drug: Cyclosporin;   Drug: Tacrolimus;   Behavioral: Diabetes Education / Management
17 Unknown  Improving the Care of Diabetic Patients: A Randomized Trial of a Family Physician Office-Based Chronic Disease Care Model for Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Other: multidisciplinary approach;   Other: multifactorial approach - for enhanced care group;   Other: reflects current patterns of care
18 Unknown  Sitagliptin in Prevention of Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin;   Other: life style modification at base line
19 Recruiting Validation of a Patient Decision Aid for Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Use of a PDA to assist shared decision making
20 Recruiting The Role of Gut Hormones and Hepcidin in Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Intervention: Other: No intervention

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years